Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Account Payables: 2020-2025

Historic Change in Account Payables for AC Immune (ACIU) over the last 3 years, with Sep 2025 value amounting to -$1.2 million.

  • AC Immune's Change in Account Payables fell 5161.39% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $592,413, marking a year-over-year increase of 3219.50%. This contributed to the annual value of $1.1 million for FY2024, which is 28.48% up from last year.
  • AC Immune's Change in Account Payables amounted to -$1.2 million in Q3 2025, which was down 254.07% from $748,892 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Change in Account Payables registered a high of $2.0 million during Q4 2021, and its lowest value of -$1.6 million during Q2 2024.
  • Over the past 3 years, AC Immune's median Change in Account Payables value was $224,882 (recorded in 2023), while the average stood at $109,114.
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 519.51% in 2024, then crashed by 5,161.39% in 2025.
  • AC Immune's Change in Account Payables (Quarterly) stood at $2.0 million in 2021, then reached $228,853 in 2023, then spiked by 519.51% to $1.4 million in 2024, then plummeted by 5,161.39% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, $748,892 for Q2 2025, and -$420,431 during Q1 2025.